Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids - Wikidata - awgldk - TriplyDB

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

http://www.wikidata.org/entity/Q35563114

about

Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma Adenosine receptors and asthma.Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Montelukast: data from clinical trials in the management of asthma.Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients New perspectives for asthma treatment: anti-leukotriene drugs.Alternative strategies in the treatment of bronchial asthma.Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist.The role of leukotrienes in the regulation of tone and responsiveness in isolated human airways.Effects of antileukotrienes in the treatment of asthma.Anti-leukotrienes in asthma: yet to arrive.The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Leukotriene receptor antagonists in the treatment of asthma: an update.New migraine preventive options: an update with pathophysiological considerations.Management of asthma in adults: current therapy and future directions Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial PPARalpha/gamma-Independent Effects of PPARalpha/gamma Ligands on Cysteinyl Leukotriene Production in Mast Cells Comparative clinical evaluation of ketotifen and montelukast sodium in asthmatic Iraqi patients.Montelukast in the treatment of asthma as a systemic disease.Montelukast in the treatment of asthma and beyond.Montelukast, current indications and prospective future applications.Anti-leukotrienes in Childhood Asthma.Implication of the small GTPase Rac1 in the generation of reactive oxygen species in response to beta-amyloid in C6 astroglioma cells.A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.Montelukast prevents antigen-induced mucociliary dysfunction in sheep.Asthma control and patient satisfaction among early pediatric users of montelukast.Prehospital asthma management.

P2860

Q24197585-B443A7DC-A77F-44F1-975C-685C11C183C1 Q24197682-63445ABE-97F0-423D-A532-90EA2C1D152B Q24247433-1CAF72F5-C839-473B-95B4-11AEC19DAFA1 Q24247489-29CD7FE8-7E62-4E4C-AB3D-3E2163D52691 Q24653697-E9D6D0FE-AC24-456C-8165-F116FAB15AE1 Q26769046-FE7CE7D7-F99A-4E1F-AE16-EB2589CD0480 Q28587590-7E134AA9-E8E2-4E82-8C88-15D6DC7DDBA6 Q30234961-84E0205A-10A1-4D57-A3A6-BB0EC930B288 Q31448541-DE4AEC0C-09DD-473C-9287-FB8238E60E40 Q33595339-CC8D38A2-4EED-472D-947F-2116E613573A Q33627353-9C01EBAC-ED14-4018-8E3D-3DF8539F5C64 Q33729339-57D4424A-10F8-4569-BBE9-CC18A0828DE8 Q33801225-FF0C947A-87F7-444E-B229-E834C22F6D0F Q33805187-90AED401-6459-4AF9-A9A7-CFB54431507F Q33836674-A6A7A218-F6F0-4837-BB2B-186D220B5B95 Q33836716-52C3238C-8AF8-4040-8A62-6456FB69EF5A Q33836725-6035A99D-D7C0-4199-B301-C29738C1635B Q33930448-17A36F2A-AE00-49BE-9908-7AB13379CCC9 Q34291204-11B42698-C6AF-4D17-8FDB-FBDC2EDE584A Q34424227-1FAD1E61-677B-4F47-81FB-DC7DFDFC2C9D Q34764665-812CA903-40B4-46C5-B2BC-34E05D1A029B Q35075798-9A386DF9-456B-4515-A6D7-3675B42252D4 Q35143482-DADB85FC-4798-45D3-AB31-0EAAC14762B6 Q35332973-2724B37D-F1C1-4852-B8EA-ED625600A919 Q35533728-3246D8BF-2865-4082-8B7C-D6CB3D0AC90B Q35537471-C91A2DD4-C579-4096-8633-AC47430BD3F7 Q36351758-182E6FF8-64B3-4726-AEAA-CE5582CB86DC Q36969079-06F37E3D-C4FF-4A3F-ACB9-87FC24411381 Q37063284-95E901AB-5AF8-43CA-B83D-4596B8F37EF6 Q37754612-D6287889-37C2-4295-B992-04708689EBD3 Q37755326-8B83EF42-B791-4486-B82E-2AAC7BE43E30 Q38835130-71EC5F7F-EB9D-47E2-A8C2-111AF4F398A5 Q42046917-C0DC0E56-3CFF-41A2-8E6E-3B0B9650F278 Q42106872-80698081-52F7-4250-8DFD-EEAD0A43F1F4 Q42862537-5729E286-CF82-445B-BD78-E08801780E2C Q42880994-21285D9A-0EAF-4FB8-BF15-00510304D397 Q43505948-75F31447-63D7-4CF7-9144-78F610DD53F0 Q44198459-ACF7ED35-5DAF-4D94-B380-2C2F0A24E7ED Q44266319-57943F8A-410E-4C00-B904-81B1EBCE009E Q44286123-9E2A142C-F864-498F-AB2D-B5950214B730

P2860

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

http://www.wikidata.org/entity/Q35563114

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@ast

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@en

type

label

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@ast

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@en

prefLabel

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@ast

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@en

P1433

Q35563114-734DF4B1-B9AE-4E7F-9422-D4C0A7005255

P1476

Q35563114-BCBAD3BD-3B26-4C5B-97F3-68905F999842

P2093

Q35563114-4E620251-1543-4844-815B-BD4B518F72AE

Q35563114-5B94DF37-D317-4A3B-B856-EEC4789DA3BE

Q35563114-60A4D0F8-8582-4A20-87AA-717A4CFED4AC

Q35563114-64D2270F-09D7-4AD7-9BAA-9D683D41D53C

Q35563114-B89692F1-D602-4FA3-9C2E-F7CFB517B05D

Q35563114-BB4C20C6-9B43-42DE-B206-7F37220D2040

Q35563114-E38F6578-45F4-4F23-8F69-9820B5C31B30

P2860

Q35563114-013C3279-368B-4C3E-8857-944FA4E83BE4

Q35563114-24FAD5DB-575F-4A8C-8C7F-A8B008B2132A

Q35563114-83E969BA-8A2E-4D91-94D7-4D6175368DBF

Q35563114-A40F5907-31C3-4CA9-869C-6C6C76FC14CB

Q35563114-BE3838A6-5C65-4318-88A4-F572A1AE492C

P304

Q35563114-F0EBF44A-7BD5-44D6-90AE-D6637DD3CAC2

P31

Q35563114-0707972E-55AC-46E0-AFBC-41C4F504C298

P356

Q35563114-D392907F-17E8-4B90-8283-E0DA93913869

P407

Q35563114-F9C7C9AE-2308-4C8B-9BBC-1F846D8B1814

P433

Q35563114-34753849-138D-4309-BF78-BA7A291EF488

P478

Q35563114-6B5A7B4C-5DB9-4D9B-89B3-DB4D5B1CF023

P577

Q35563114-A5B12923-FFFB-49C1-AA5C-8DB5E7C57DA0

P5875

Q35563114-AD2B6FA2-C249-4C8E-B963-5DA81B57AEBC

P698

Q35563114-48D5C756-13AF-47FC-84A0-EC1D4F346BA9

P921

Q35563114-0E28E2BE-8CB8-483E-B105-40C27EBEC3C2

P932

Q35563114-781FE073-C1CB-40C7-AA2E-C275A12539A1

P356

P1433

P1476

Effects of montelukast (MK-047 ...... ithout inhaled corticosteroids

@en

P2093

Botto A

http://www.w3.org/2001/XMLSchema#string

Busse WW

http://www.w3.org/2001/XMLSchema#string

Kundu S

http://www.w3.org/2001/XMLSchema#string

Reiss TF

http://www.w3.org/2001/XMLSchema#string

Sorkness CA

http://www.w3.org/2001/XMLSchema#string

Stricker W

http://www.w3.org/2001/XMLSchema#string

Zhang J

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist

Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.

P304

45-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.52.1.45

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14172120

http://www.w3.org/2001/XMLSchema#string

P698

9039239

http://www.w3.org/2001/XMLSchema#string

P921

P932

1758407

http://www.w3.org/2001/XMLSchema#string